Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market Size, Share & Trends Analysis Report 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global malaria diagnostics market size is projected to reach USD 1.17 billion by 2030, expanding at a CAGR of 4.73%.
Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth.
Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.
Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.
A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control.
Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.
Companies Mentioned
- Access Bio., Inc.
- Abbott Laboratories
- Premier Medical Corporation Pvt. Ltd.
- Sysmex Partec GmbH
- bioMerieux
- Beckman Coulter, Inc.
- Siemens Healthineers
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Bio-Rad Laboratories, Inc.
Malaria Diagnostics Market Report Highlights
- Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
- RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis
- The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count
- Africa led the market in 2022 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region
- Southeast Asia is expected to grow at a CAGR of 5.0% owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 84 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $786.51 Million |
| Forecasted Market Value (USD) by 2030 | $1170 Million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing demand for diagnostic tools in malaria-endemic countries
3.4.2. Development of technologically advanced and efficient diagnostics
3.4.3. Market players and private investors to curb the prevalence of malaria
3.5. Market Restraint Analysis
3.5.1. Increasing number of countries in the malaria elimination phase
3.5.2. Demand for low-cost malaria diagnostic tests
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter's Five Forces Analysis
3.7. COVID-19 Impact Analysis
Chapter 4. Malaria Diagnostics Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)
4.1. Malaria Diagnostics Market: Technology Movement Analysis
4.2. Microscopy
4.2.1. Microscopy Market, 2018 - 2030 (USD Million)
4.3. Rapid Diagnostic Tests (RDTs)
4.3.1. Rapid Diagnostic Tests (RDTs) Market, 2018 - 2030 (USD Million)
4.4. Molecular Diagnostic Tests
4.4.1. Molecular Diagnostic Tests Market, 2018 - 2030 (USD Million)
4.4.2. Conventional PCR
4.4.2.1. Conventional PCR Market, 2018 - 2030 (USD Million
4.4.3. Real-Time PCR (qPCR or quantitative PCR)
4.4.3.1. Real-Time PCR (qPCR or quantitative PCR) Market, 2018 - 2030 (USD Million)
Chapter 5. Malaria Diagnostics Market - Segment Analysis, By End-use, 2018 - 2030 (USD Million)
5.1. Malaria Diagnostics Market: End-use Movement Analysis
5.2. Clinics
5.2.1. Clinics Market, 2018 - 2030 (USD Million)
5.3. Hospitals
5.3.1. Hospitals Market, 2018 - 2030 (USD Million)
5.4. Diagnostic Centers
5.4.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
Chapter 7. Competitive Landscape
7.1 Company Categorization
7.2 Strategy Mapping
7.2.1 New Product Launch
7.2.2 Partnerships
7.2.3 Acquisition
7.2.4 Collaboration
7.2.5 Funding
7.3 Key Company Market Share Analysis, 2022
7.4 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/672kuj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
